Advertisement

Loading...

Body and Mind Inc.

BAMM.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$0.00(0.00%)
Canadian Market opens in 16h 37m

Body and Mind Inc. Fundamental Analysis

Body and Mind Inc. (BAMM.CN) shows moderate financial fundamentals with a PE ratio of -0.11, profit margin of -92.14%, and ROE of 65.27%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE65.27%
Cash Position44.99%
PEG Ratio-0.00

Areas of Concern

Operating Margin-33.61%
We analyze BAMM.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -4.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-4.7/100

We analyze BAMM.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

BAMM.CN struggles to generate sufficient returns from assets.

ROA > 10%
-99.14%

Valuation Score

Excellent

BAMM.CN trades at attractive valuation levels.

PE < 25
-0.11
PEG Ratio < 2
-0.00

Growth Score

Weak

BAMM.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

BAMM.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
-1.94
Current Ratio > 1
1.21

Profitability Score

Weak

BAMM.CN struggles to sustain strong margins.

ROE > 15%
65.27%
Net Margin ≥ 15%
-92.14%
Positive Free Cash Flow
No

Key Financial Metrics

Is BAMM.CN Expensive or Cheap?

P/E Ratio

BAMM.CN trades at -0.11 times earnings. This suggests potential undervaluation.

-0.11

PEG Ratio

When adjusting for growth, BAMM.CN's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Body and Mind Inc. at -0.23 times its book value. This may indicate undervaluation.

-0.23

EV/EBITDA

Enterprise value stands at 1.08 times EBITDA. This is generally considered low.

1.08

How Well Does BAMM.CN Make Money?

Net Profit Margin

For every $100 in sales, Body and Mind Inc. keeps $-92.14 as profit after all expenses.

-92.14%

Operating Margin

Core operations generate -33.61 in profit for every $100 in revenue, before interest and taxes.

-33.61%

ROE

Management delivers $65.27 in profit for every $100 of shareholder equity.

65.27%

ROA

Body and Mind Inc. generates $-99.14 in profit for every $100 in assets, demonstrating efficient asset deployment.

-99.14%

Following the Money - Real Cash Generation

Operating Cash Flow

Body and Mind Inc. generates limited operating cash flow of $-4.21M, signaling weaker underlying cash strength.

$-4.21M

Free Cash Flow

Body and Mind Inc. generates weak or negative free cash flow of $-5.31M, restricting financial flexibility.

$-5.31M

FCF Per Share

Each share generates $-0.04 in free cash annually.

$-0.04

FCF Yield

BAMM.CN converts -1.82% of its market value into free cash.

-1.82%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.11

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.23

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.12

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.94

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.21

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

65.27

vs 25 benchmark

ROA

Return on assets percentage

-0.99

vs 25 benchmark

ROCE

Return on capital employed

-0.57

vs 25 benchmark

How BAMM.CN Stacks Against Its Sector Peers

MetricBAMM.CN ValueSector AveragePerformance
P/E Ratio-0.1127.91 Better (Cheaper)
ROE6526.55%687.00% Excellent
Net Margin-92.14%-45285.00% (disorted) Weak
Debt/Equity-1.940.33 Strong (Low Leverage)
Current Ratio1.212795.76 Neutral
ROA-99.14%-13557.00% (disorted) Weak

BAMM.CN outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Body and Mind Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ